Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: Evidence for altered receptor conformations

Endocrinology

Volumn 142, Issue 4, 2001, Pages 1534-1545

  Carter, P H ^a   Petroni, B D ^a   Gensure, R C ^a   Schipani, E ^a   Potts J T , Jr ^a   Gardella, T J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLIC AMP; LEUCINE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; TRYPTOPHAN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR INTRINSIC ACTIVITY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0035049091     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.4.8103     Document Type: Article

References (37)

1. The PTH/PTHrP receptor: One receptor for two ligands
2. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia
3. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia
4. Constitutively activated receptors for parathyroid hormone and parathyroid hormone related peptide in Jansen's metaphyseal chondrodysplasia
5. Constitutive activation of the cyclic adenosine 3′,5′-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia
6. Targeted expression of constitutively active PTH/PTHrP receptors delays endochondral bone formation and rescues PTHrP-less mice
7. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors
8. Inverse agonism at G protein coupled receptors: (Patho)physiological relevance and implications for drug discovery
9. Negative antagonists promote an inactive conformation of the β2-adrenergic receptor
10. Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins
11. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
12. Studies of the N-terminal region of a parathyroid hormone-related peptide(1-36) analog: Receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents
13. Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist
14. Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor
15. Residues in the membrane-spanning and extracellular loop regions of the PTH-2 receptor determine signaling selectivity for PTH and PTH-related peptide
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Nonlinear regression using spreadsheets
18. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2
19. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: Toward the design of highly potent antagonists
20. Pharmacology of parathyroid hormone and some of its fragments and analogues
21. Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features
22. Agonist-independent regulation of constitutively active G-protein-coupled receptors
23. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor
24. Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization
25. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves arrestin2
26. Role of signal transduction in internalization of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein
27. Over-expression of beta arrestin-2 in LL-CPK-1 cells stably expressing a green fluorescent protein-tagged PTH/PTHrP receptor increases internalization
28. Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor
29. Residues within the third extracellular loops of the parathyroid hormone type-1 and type-2 receptors determine the receptorselective antagonist properties of [Bpa2,IIe5,Trp23]-PTHrP(1-36)
30. Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone
31. The hydrophobic residues phenylalanine 184 and leucine 187 in the type-1 parathyroid hormone (PTH) receptor functionally interact with the amino-terminal portion of PTH (1-34)
32. Molecular characterization of the receptor-ligand complex for parathyroid hormone
33. Conformation of parathyroid hormone antagonists by CD, NMR, and molecular dynamics simulations
34. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation
35. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis
36. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor
37. Protean agonists. Keys to receptor active states?